If you are taking chronic prescription medication, consult your health care practitioner before using this product
This is a large dataset and a positive step toward clinical validation
Its anti-atherogenic actions include nitric oxide production, inhibition of cell proliferation in vascular smooth muscle cell proliferation, and suppression of inflammatory responses in monocytes, macrophages, and adipocytes
What patients do report, usually transiently, includes a brief injection-site reaction, mild flushing across the face or chest for a few minutes after injection, and occasional tingling in the hands or feet that can signal the dose needs adjusting
This likely contributes to GHK-Cus cardiovascular and tissue protective effects